Adam R. Borden, MHA
Senior Vice President, Policy & Strategy at the American Clinical Laboratory Association (ACLA)
Adam R. Borden is the Vice President of Market Access and Reimbursement at Cleerly, Inc. Adam has had a diverse career in healthcare and has developed deep knowledge and understanding of federal health policy, provider reimbursement, and the changing landscape of healthcare delivery in the United States. Adam currently leads market access and reimbursement efforts for Cleerly's AI-based products aimed at predicting risk and preventing heart attacks.
Prior to joining Cleerly, Adam spent five years at Siemens Healthineers leading policy and reimbursement strategy for all business areas. During this time, Adam also served as Chair of the Reimbursement Committee at the Medical Imaging & Technology Alliance (MITA) and Chair of the Diagnostics Payment Work Group at AdvaMedDx. Adam was also a Vice President at the premier D.C.-based policy consulting firm, Avalere Health. At Avalere, Adam worked closely with life sciences manufacturers, providers and advocacy groups on policy, reimbursement, value messaging, and market access strategies and engagements.
Earlier in his career, Adam worked in policy and reimbursement at the American Gastroenterological Association and in financial management and clinical education roles at several leading academic medical centers.
Adam holds a Bachelor of Arts degree from Rutgers University and a Master of Health Administration degree from A.T. Still University of Health Sciences.